Back to search

Peptide record

TPDB02721

Antibacterial Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02721
Antibacterial Anticancer
Anti-infective peptides Cancer-related peptides
AntiBP3 Peptipedia CancerPPD 2.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial and Anticancer) peptide sequence curated from AntiBP3, Peptipedia, and CancerPPD 2.0, with an available 3D structural model.
Sequence
FLSGIVGMLAKLF
Physicochemical Analysis
C68H110N14O15S1
RNDCEQHPTWY
L
1395.77
10.10
1
0
9
+1
-3.44
1.838
150.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
2
G
0
H
1
I
3
L
1
K
1
M
2
F
0
P
1
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 3 K: 1 M: 1 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
13
C68H110N14O15S1
1395.77
10.10
+1
-3.44
1.838
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

A. baumannii DSM 30007

Source & Reference

NA

Other

active against Gram- bacteria A. baumannii DSM 30007 (MIC 12.5 uM), E.cloacae DSM 30054 (MIC >100 uM), E. coli ATCC 8739 (MIC 100 uM), H. pylori ATCC 43504
Evidence 2 Activity

Activity

MIC
Antibacterial
>100 µM

Target

E.cloacae DSM 30054

Source & Reference

NA

Other

active against Gram- bacteria A. baumannii DSM 30007 (MIC 12.5 uM), E.cloacae DSM 30054 (MIC >100 uM), E. coli ATCC 8739 (MIC 100 uM), H. pylori ATCC 43504 (MIC 3.12 uM), K. pneumonia DSM 263
Evidence 3 Activity

Activity

MIC
Antibacterial
100 µM

Target

Escherichia coli ATCC 8739

Source & Reference

NA

Other

t Gram- bacteria A. baumannii DSM 30007 (MIC 12.5 uM), E.cloacae DSM 30054 (MIC >100 uM), E. coli ATCC 8739 (MIC 100 uM), H. pylori ATCC 43504 (MIC 3.12 uM), K. pneumonia DSM 26371 (MIC 100 uM), P.aeruginosa AT
Evidence 4 Activity

Activity

MIC
Antibacterial
3.12 µM

Target

H. pylori ATCC 43504

Source & Reference

NA

Other

M 30007 (MIC 12.5 uM), E.cloacae DSM 30054 (MIC >100 uM), E. coli ATCC 8739 (MIC 100 uM), H. pylori ATCC 43504 (MIC 3.12 uM), K. pneumonia DSM 26371 (MIC 100 uM), P.aeruginosa ATCC 9027 (MIC > 100 uM), Gram+ bacter
Evidence 5 Activity

Activity

MIC
Antibacterial
100 µM

Target

K. pneumonia DSM 26371

Source & Reference

NA

Other

30054 (MIC >100 uM), E. coli ATCC 8739 (MIC 100 uM), H. pylori ATCC 43504 (MIC 3.12 uM), K. pneumonia DSM 26371 (MIC 100 uM), P.aeruginosa ATCC 9027 (MIC > 100 uM), Gram+ bacteria B. subtilis ATCC 6633 (MIC 3.12 uM
Evidence 6 Activity

Activity

MIC
Antibacterial
3.12 µM

Target

B. subtilis ATCC 6633

Source & Reference

NA

Other

. pneumonia DSM 26371 (MIC 100 uM), P.aeruginosa ATCC 9027 (MIC > 100 uM), Gram+ bacteria B. subtilis ATCC 6633 (MIC 3.12 uM), E. faecalis DSM 2570 (MIC 25 uM), E.faecium DSM 20477 (MIC >100 uM), and S. aureus ATCC
Evidence 7 Activity

Activity

MIC
Antibacterial
25 µM

Target

Enterococcus faecalis DSM 2570

Source & Reference

NA

Other

.aeruginosa ATCC 9027 (MIC > 100 uM), Gram+ bacteria B. subtilis ATCC 6633 (MIC 3.12 uM), E. faecalis DSM 2570 (MIC 25 uM), E.faecium DSM 20477 (MIC >100 uM), and S. aureus ATCC 6538 (MIC 3.12 uM). Anticancer: Br
Evidence 8 Activity

Activity

MIC
Antibacterial
>100 µM

Target

E.faecium DSM 20477

Source & Reference

NA

Other

M), Gram+ bacteria B. subtilis ATCC 6633 (MIC 3.12 uM), E. faecalis DSM 2570 (MIC 25 uM), E.faecium DSM 20477 (MIC >100 uM), and S. aureus ATCC 6538 (MIC 3.12 uM). Anticancer: Breast Cancer MCF-7, Liver Cancer Hep
Evidence 9 Activity

Activity

MIC
Antibacterial
3.12 µM

Target

Staphylococcus aureus ATCC 6538

Source & Reference

NA

Other

3 (MIC 3.12 uM), E. faecalis DSM 2570 (MIC 25 uM), E.faecium DSM 20477 (MIC >100 uM), and S. aureus ATCC 6538 (MIC 3.12 uM). Anticancer: Breast Cancer MCF-7, Liver Cancer HepG-2, Ovarian Cancer A2780, Pancreatic C